Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86457792 | 8645779 | 2 | F | 20160906 | 20120702 | 20160912 | EXP | US-ROCHE-1082407 | ROCHE | MCLEON M. ACUTE PULMONARY EMBOLISM. CRIT CARE NURS Q 2012 APR;35 (2):173-182. | 75.00 | YR | F | Y | 0.00000 | 20160912 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86457792 | 8645779 | 1 | PS | Actilyse | ALTEPLASE | 1 | Intravenous (not otherwise specified) | OVER 2 HOURS | 103172 | SOLUTION FOR INFUSION | |||||||||
| 86457792 | 8645779 | 2 | SS | ENOXAPARIN | ENOXAPARIN | 1 | Subcutaneous | ENOXAPARIN: 1 MG/KG | 0 | 70 | MG | BID | |||||||
| 86457792 | 8645779 | 3 | SS | HEPARIN | HEPARIN SODIUM | 1 | Subcutaneous | 0 | 1 | MG/KG | Q12H | ||||||||
| 86457792 | 8645779 | 4 | SS | BIVALIRUDIN. | BIVALIRUDIN | 1 | Unknown | 0 | INFUSION | ||||||||||
| 86457792 | 8645779 | 5 | C | BIOTIN | BIOTIN | 1 | Oral | 0 | 1000 | UG | QD | ||||||||
| 86457792 | 8645779 | 6 | C | CITRACAL (CALCIUM CITRATE) | CALCIUM CITRATE | 1 | Oral | 0 | 630 | MG | TABLET | QD | |||||||
| 86457792 | 8645779 | 7 | C | DOCUSATE | DOCUSATE | 1 | Oral | AS NEEDED | 0 | 100 | MG | TABLET | BID | ||||||
| 86457792 | 8645779 | 8 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 86457792 | 8645779 | 9 | C | VITAMIN B1 | THIAMINE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 86457792 | 8645779 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 0 | 40 | MG | QD | ||||||||
| 86457792 | 8645779 | 11 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | Unknown | NEBULIZER ROUTE INHALATION | 0 | .63 | MG | Q6H | |||||||
| 86457792 | 8645779 | 12 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 2 | G | Q12H | ||||||||
| 86457792 | 8645779 | 13 | C | LINEZOLID. | LINEZOLID | 1 | Intravenous (not otherwise specified) | 0 | 600 | MG | Q12H | ||||||||
| 86457792 | 8645779 | 14 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | Q8H | ||||||||
| 86457792 | 8645779 | 15 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | 0 | 50 | MG | Q6H | ||||||||
| 86457792 | 8645779 | 16 | C | AMIODARONE | AMIODARONE | 1 | Intravenous (not otherwise specified) | 0 | .5 | MG | /min | ||||||||
| 86457792 | 8645779 | 17 | C | DOBUTAMINE | DOBUTAMINEDOBUTAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 15 | UG/KG | /min | ||||||||
| 86457792 | 8645779 | 18 | C | DOPAMINE | DOPAMINEDOPAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 20 | UG/KG | /min | ||||||||
| 86457792 | 8645779 | 19 | C | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | Intravenous (not otherwise specified) | 0 | 10 | UG | /min | ||||||||
| 86457792 | 8645779 | 20 | C | VASOPRESSIN. | VASOPRESSIN | 1 | Intravenous (not otherwise specified) | 57.6 U (0.04 U, 1 IN 1 MINUTE) | 0 | /min | |||||||||
| 86457792 | 8645779 | 21 | C | FENTANYL. | FENTANYL | 1 | Intravenous (not otherwise specified) | 0 | 50 | UG | /hr | ||||||||
| 86457792 | 8645779 | 22 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | AS REQUIRED | 0 | .5 | MG | ||||||||
| 86457792 | 8645779 | 23 | C | SALINE | SODIUM CHLORIDE | 1 | Nasal | 1 SPRAY INTO NOSTRILS | 0 | SUSPENSION AND SOLUTION FOR SPRAY | BID | ||||||||
| 86457792 | 8645779 | 24 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 100 | MG | BID | ||||||||
| 86457792 | 8645779 | 25 | C | ACETYLCYSTEINE. | ACETYLCYSTEINE | 1 | Unknown | NEBULIZER AND ROUTE INHALATION | 0 | Q6H | |||||||||
| 86457792 | 8645779 | 26 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 200 | ML | /hr | ||||||||
| 86457792 | 8645779 | 27 | C | INSULIN | INSULIN NOS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 86457792 | 8645779 | 1 | Pulmonary embolism |
| 86457792 | 8645779 | 2 | Pulmonary embolism |
| 86457792 | 8645779 | 3 | Pulmonary embolism |
| 86457792 | 8645779 | 4 | Pulmonary embolism |
| 86457792 | 8645779 | 22 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 86457792 | 8645779 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 86457792 | 8645779 | Anaemia | |
| 86457792 | 8645779 | Cardiogenic shock | |
| 86457792 | 8645779 | Coagulopathy | |
| 86457792 | 8645779 | Encephalopathy | |
| 86457792 | 8645779 | Hepatic failure | |
| 86457792 | 8645779 | Multiple organ dysfunction syndrome | |
| 86457792 | 8645779 | Renal failure | |
| 86457792 | 8645779 | Respiratory failure | |
| 86457792 | 8645779 | Septic shock | |
| 86457792 | 8645779 | Thrombocytopenia | |
| 86457792 | 8645779 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |